Targeting SHP2 as a therapeutic strategy for inflammatory diseases

被引：28
作者：
Liu, Yang [1 ]
Yang, Xiaohe [1 ]
Wang, Yali [1 ]
Yang, Yueying [1 ]
Sun, Dejuan [1 ]
Li, Hua [1 ,2 ]
Chen, Lixia [1 ]
机构：
[1] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Key Lab Struct Based Drug Design & Discovery, Minist Educ, Shenyang 110016, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Hubei Key Lab Nat Med Chem & Resource Evaluat, Wuhan 430030, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2021年 / 214卷
基金：
中国国家自然科学基金;
关键词：
SHP2; inhibitors; Inflammation; Cancer; TYROSINE-PHOSPHATASE SHP2; SMALL HETERODIMER PARTNER; HELICOBACTER-PYLORI; HEMATOPOIETIC STEM; FEEDBACK-REGULATION; INSULIN-RESISTANCE; CANCER-CELLS; INHIBITION; ACTIVATION; RECEPTOR;
D O I：
10.1016/j.ejmech.2021.113264
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
With the change of lifestyle and the acceleration of aging process, inflammatory diseases have increasingly become one of the most vital threats to global human health. SHP2 protein is a non-receptor tyrosine phosphatase encoded by PTPN11 gene, and it is widely expressed in various tissues and cells. Numerous studies have shown that SHP2 plays important roles in the regulation of inflammatory diseases, including cancer-related inflammation, neurodegenerative diseases and metabolic diseases. In this paper, the roles of SHP2 in inflammatory diseases of various physiological systems were reviewed. At the same time, the latest SHP2 inhibitors were summarized, which will hold a promise for the therapeutic potential in future. (C) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数：16
相关论文
共 156 条
[121]   Amelioration of Acute Kidney Injury in Lipopolysaccharide-Induced Systemic Inflammatory Response Syndrome by an Aldose Reductase Inhibitor, Fidarestat [J].
Takahashi, Kazunori ;
Mizukami, Hiroki ;
Kamata, Kosuke ;
Inaba, Wataru ;
Kato, Noriaki ;
Hibi, Chihiro ;
Yagihashi, Soroku .
PLOS ONE, 2012, 7 (01)
[122]   Myeloid-Specific Disruption of Tyrosine Phosphatase Shp2 Promotes Alternative Activation of Macrophages and Predisposes Mice to Pulmonary Fibrosis [J].
Tao, Bo ;
Jin, Wei ;
Xu, Jiaqi ;
Liang, Zuyu ;
Yao, Junlin ;
Zhang, Yun ;
Wang, Kai ;
Cheng, Hongqiang ;
Zhang, Xue ;
Ke, Yuehai .
JOURNAL OF IMMUNOLOGY, 2014, 193 (06) :2801-2811
[123]   Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome [J].
Tartaglia, M ;
Mehler, EL ;
Goldberg, R ;
Zampino, G ;
Brunner, HG ;
Kremer, H ;
van der Burgt, I ;
Crosby, AH ;
Ion, A ;
Jeffery, S ;
Kalidas, K ;
Patton, MA ;
Kucherlapati, RS ;
Gelb, BD .
NATURE GENETICS, 2001, 29 (04) :465-468
[124]   A novel function for the protein tyrosine phosphatase Shp2 during lung branching morphogenesis [J].
Tefft, D ;
De Langhe, SP ;
Del Moral, PM ;
Sala, F ;
Shi, W ;
Bellusci, S ;
Warburton, D .
DEVELOPMENTAL BIOLOGY, 2005, 282 (02) :422-431
[125]   RETRACTED: Lentivirus-Mediated Silencing of Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase 2 Inhibits Release of Inflammatory Cytokines and Apoptosis in Renal Tubular Epithelial Cells Via Inhibition of the TLR4/NF-κB Pathway in Renal Ischemia-Reperfusion Injury (Retracted Article) [J].
Teng, Jing-Fei ;
Wang, Kai ;
Jia, Zhuo-Min ;
Guo, Yan-Jie ;
Guan, Ya-Wei ;
Li, Zhi-Hui ;
Ai, Xing .
KIDNEY & BLOOD PRESSURE RESEARCH, 2018, 43 (04) :1084-1103
[126]   Targeting Inflammation in Cancer Prevention and Therapy [J].
Todoric, Jelena ;
Antonucci, Laura ;
Karin, Michael .
CANCER PREVENTION RESEARCH, 2016, 9 (12) :895-905
[127]   Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies [J].
Tsilidis, Konstantinos K. ;
Kasimis, John C. ;
Lopez, David S. ;
Ntzani, Evangelia E. ;
Ioannidis, John P. A. .
BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
[128]   Nitric Oxide Is Involved in Activation of Toll-Like Receptor 4 Signaling through Tyrosine Nitration of Src Homology Protein Tyrosine Phosphatase 2 in Murine Dextran Sulfate-Induced Colitis [J].
Tun, Xin ;
Yasukawa, Keiji ;
Yamada, Ken-ichi .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2018, 41 (12) :1843-1852
[129]   Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein [J].
Wang, Mingliang ;
Lu, Jianfeng ;
Wang, Mi ;
Yang, Chao-Yie ;
Wang, Shaomeng .
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (14) :7510-7528
[130]   Synthesis and biological evaluation of novel bis-aromatic amides as novel PTP1B inhibitors [J].
Wang, Wen-Long ;
Huang, Chao ;
Gao, Li-Xin ;
Tang, Chun-Lan ;
Wang, Jun-Qing ;
Wu, Min-Chen ;
Sheng, Li ;
Chen, Hai-Jun ;
Nan, Fa-Jun ;
Li, Jing-Ya ;
Li, Jia ;
Feng, Bainian .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (08) :1889-1894
78910111213141516